Discover 2,299 paid clinical trials in Oakland, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,299
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
for
Atrial Fibrillation (AF)
Location: Fremont CA, Santa Rosa CA, Redding CA, Ventura CA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07175428
Phase 2, Recruiting
EyeConic: Qualification for Cone-Optogenetics
for
Retinal Dystrophies
Location: San Francisco CA, Pittsburgh PA, Miami FL
Sponsor: Institute of Molecular and Clinical Ophthalmology Basel
Sex: All
Age: 0+
Code: NCT05294978
Recruiting
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
for
Schizophrenia, Autism-Related Irritability
Location: San Francisco CA, Culver City CA, Chino CA, Anaheim CA,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 5 - 17
Code: NCT07424404
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
for
Schizophrenia
Location: San Francisco CA, Culver City CA, Chino CA, Anaheim CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 13 - 17
Code: NCT07288567
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for
Parkinson's Disease
Location: San Francisco CA, Palo Alto CA, Stanford CA, Reno NV,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07174310
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Deep Brain Stimulation for Spinocerebellar Ataxia
for
Spinocerebellar Ataxia (SCA), Spinocerebellar Ataxia Type 6
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
for
Early Alzheimer's Disease
Location: San Francisco CA, Los Angeles CA, Long Beach CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 50 - 70+
Code: NCT07033494
Phase 2, Recruiting
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: San Francisco CA, Los Angeles CA, Fullerton CA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06203210
Phase 3, Recruiting
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Location: San Francisco CA, Santa Monica CA, Houston TX,
Sponsor: Bayer
Sex: All
Age: 18+
Code: NCT06452277
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: San Francisco CA, Los Angeles CA, Portland OR,
Sponsor: Dianthus Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06858579
Phase 3, Recruiting
A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
for
COVID-19, SARS-CoV-2 Infection
Location: San Francisco CA, Los Angeles CA
Sponsor: Kara Chew
Sex: All
Age: 40 - 64
Code: NCT06810934
Phase 1, Phase 2, Recruiting
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
for
Recurrent Childhood Acute Myeloid Leukemia,
Location: San Francisco CA, Orange CA, Aurora CO, Minneapolis MN,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 18
Code: NCT06247787
Phase 1, Recruiting
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
Location: San Francisco CA, Los Angeles CA, Orange CA, Aurora CO,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT04851119
Phase 1, Phase 2, Recruiting
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
for
Breast Cancer, Solid Tumors, Adult
Location: San Francisco CA, Los Angeles CA, Portland OR,